Carlsmed Inc. (CARL)
CARL trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1794546/000119312526071551/0001193125-26-071551-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | CARL on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0001794546 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $50.5M |
| Net income | -$29.6M |
| Operating income | -$30.6M |
| Net margin | -58.7% |
| Operating margin | -60.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $85.8M |
| Total assets | $130.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 7.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-14 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-09-30 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 93 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.8% |
| 1 month | -9.2% |
| 3 months | +17.0% |
| Year to date | +12.0% |
| 1 year | +5.3% |
| From 52-week high | -18.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RCEL | Avita Medical Inc. | $13.36 | -0.07% | $413.2M |
| OFIX | Orthofix Medical Inc. Common Stock (DE) | $9.26 | -0.22% | $377.2M |
| SI | Shoulder Innovations Inc. | $18.07 | -0.88% | $376.2M |
| NPCE | Neuropace Inc. | $12.68 | -2.46% | $435.2M |
| EMBC | Embecta Corp. | $6.20 | +3.51% | $351.3M |
| CERS | Cerus Corporation | $2.26 | 0.00% | $455.4M |
| ANGO | AngioDynamics Inc. | $10.90 | -4.39% | $458.4M |
| SGHT | Sight Sciences Inc. | $8.39 | -6.41% | $462.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier